Issue title: Abstracts from the 7th European Symposium on Steps Forward in Pompe Disease: Turin, Italy, November 21–22, 2014
Article type: Research Article
Authors: Thurberg, Beth L. | Carlier, Pierre | Kissel, John T. | Schoser, Benedikt | Pestronk, Alan | Barohn, Richard J. | Goker-Alpan, Ozlem | Mozaffar, Tahseen | Pena, Loren D.M. | Simmons, Zachary | Straub, Volker | Young, Peter | Shafi, Raheel | Bjartmar, Carl | van der Ploeg, Ans
Affiliations: Genzyme, a Sanofi Company, Cambridge, MA, USA | Institut de Myologie, NMR Laboratory – Spectroscopy Laboratory, Université Pierre et Marie Curie, Paris, France | Department of Neurology, Division of Neuromuscular Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA | Friedrich-Baur Institut, Neurologische Klinik, Klinikum der Universität München, Munich, Germany | Neuroscience Center, Center for Advanced Medicine, St. Louis, MO, USA | Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA | Lysosomal Disorders Unit and Center for Clinical Trials, O&O Alpan LLC, Fairfax, VA, USA | Department of Neurology, University of California, Irvine, Irvine, CA, USA | Division of Pediatric Medical Genetics, Duke University Medical Center, Durham, NC, USA | Penn State Hershey Neurology, Hershey, PA, USA | Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK | Department of Sleep Medicine and Neuromuscular Disorders, University Hospital of Münster, Münster, Germany | Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, Netherlands
Note: [] Correspondence to: Beth L. Thurberg, Genzyme, a Sanofi Company, Cambridge, MA, USA. E-mail: Beth.Thurberg@genzyme.com
DOI: 10.3233/JND-159060
Journal: Journal of Neuromuscular Diseases, vol. 2, no. s1, pp. S72-S73, 2015
